ST Pharm Co.,Ltd. (KOSDAQ:237690)

Accolade Revenue

ST Pharm had revenue of 52.42B KRW in the quarter ending March 31, 2025, with 1.35% growth. This brings the company's revenue in the last twelve months to 274.45B, down -4.06% year-over-year. In the year 2024, ST Pharm had annual revenue of 273.75B, down -3.94%.

• Revenue (ttm): 274.45B
• Revenue Growth: -4.06%
• P/S Ratio: 6.61
• Revenue / Employee: 419.01M
• Employees: 655
• Market Cap: 1,813.76B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	273.75B	-11.24B	-3.94%
Dec 31, 2023	284.99B	35.67B	14.31%
Dec 31, 2022	249.32B	83.68B	50.52%
Dec 31, 2021	165.64B	41.53B	33.47%
Dec 31, 2020	124.11B	30.85B	33.08%